# Efficacy and Safety of Ganciclovir Capsules in the Treatment of Refractory Moderate-to-severe Allergic Rhinitis

> **NCT06436534** · NA · RECRUITING · sponsor: **Union Hospital, Tongji Medical College, Huazhong University of Science and Technology** · enrollment: 50 (estimated)

## Conditions studied

- Rhinitis, Allergic

## Interventions

- **DRUG:** Ganciclovir Oral Capsule
- **DRUG:** Ganciclovir Simulant Oral Capsule
- **DRUG:** Mometasone Nasal

## Key facts

- **NCT ID:** NCT06436534
- **Lead sponsor:** Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-05-24
- **Primary completion:** 2026-03
- **Final completion:** 2026-05
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2025-07-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06436534

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06436534, "Efficacy and Safety of Ganciclovir Capsules in the Treatment of Refractory Moderate-to-severe Allergic Rhinitis". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT06436534. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*